Ginsenoside Rg1 inhibits high-voltage-activated calcium channel currents in hippocampal neurons of beta-amyloid peptide-exposed rat brain slices

Chinese Journal of Integrative Medicine
Qiankun QuanWen-Li Liu

Abstract

To examine whether ginsenoside Rg1 (Rg1) inhibits the high-voltage-activated calcium currents (ICa,HVA) via mitogen-activated protein kinase (MAPK) in hippocampal neurons in rat brain slices exposed to beta-amyloid peptide 25-35 (Aβ25-35). An experimental Alzheimer disease (AD) model was prepared by exposure of rat brain slices to Aβ25-35 (10 µmol/L). After treatment with Rg1 (20 µmol/L), the ICa,HVA elicited in hippocampal neurons in these rat brain slices upon depolarization from-40 to 40 mV for 200 ms was recorded by a whole-cell patch clamp to analyze the changes in the peak current density, I-V curve, activation-V curve, and inactivation-V curve. Exposure of rat brain slices to Aβ led to a significant increase in ICa,HVA, enhancement of the voltage sensitivity of channel activation, and reduction of the voltage sensitivity of channel inactivation in neurons in the hippocampus of rat brain slices. Rg1 treatment significantly inhibited these changes. These effects of Rg1 could be effectively inhibited by the MAPK inhibitor PD98059. Rg1 can inhibit Ica,HVA via MAPK in hippocampal neurons in Aβ-exposed rat brain slices.

References

Jan 1, 1996·Annual Review of Pharmacology and Toxicology·N A Simonian, J T Coyle
Nov 26, 1999·Biochemical Pharmacology·A S AtteleC S Yuan
Nov 2, 2001·FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology·H LinR Lal
May 19, 2004·Archives of Neurology·Zoe ArvanitakisDavid A Bennett
Jan 25, 2005·Acta Pharmacologica Sinica·Yong ChengJun-Tian Zhang
Feb 26, 2010·Journal of Asian Natural Products Research·Yue-Hua Wang, Guan-Hua Du
Oct 22, 2011·Biochimica Et Biophysica Acta·Fang FangShirley Shidu Yan
Sep 19, 2012·Apoptosis : an International Journal on Programmed Cell Death·Antonio Morales-HernándezJaime M Merino

❮ Previous
Next ❯

Citations

Mar 1, 2019·Molecular Medicine Reports·Mayya Petrovna RazgonovaDemetrios A Spandidos

❮ Previous
Next ❯

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: APP

Amyloid precursor protein (APP) proteolysis is critical for the development of Alzheimer's disease, a neurodegenerative disease associated with accumulation of amyloid plaques in the brain. Here is the latest research on APP and Alzheimer's disease.